Skip to main content

Table 4 Influence of vaccination route, post hoc explorative analysis

From: Clinical outcomes of active specific immunotherapy in advanced colorectal cancer and suspected minimal residual colorectal cancer: a meta-analysis and system review

vaccine

clinical benefit rate

s.c

73/215(34.0%)

i.m

16/80(20.0%)

i.d

31/120(25.0%)

i.v

15/76(19.7%)